Principal Financial Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
84,990
+6,443
+8% +$164K ﹤0.01% 1827
2026
Q1
$1.97M Buy
+78,547
New +$1.86M ﹤0.01% 1829
2024
Q3
Sell
-30,642
Closed -$261K 2420
2024
Q2
$261K Buy
30,642
+4,671
+18% +$41.6K ﹤0.01% 2087
2024
Q1
$273K Buy
+25,971
New +$288K ﹤0.01% 2107

Other funds holding ZYME

Principal Financial Group's ZYME Position: Q2 2026 in Review

Principal Financial Group increased its Zymeworks (ZYME) stake by 8.2% in Q2 2026, buying an estimated $164K and bringing the position to 84,990 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Principal Financial Group first reported a position in ZYME in Q1 2024 and has held it in 4 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Principal Financial Group held 84,990 shares of Zymeworks worth $2.22M as of Q2 2026.
  • Principal Financial Group bought 6,443 Zymeworks shares in Q2 2026, an estimated $164K.
  • Zymeworks made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1827 holding.
  • Principal Financial Group first reported a position in Zymeworks in Q1 2024 and has held it in 4 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.